Healthcare provider profile · identity verified

Gregory Brian Dye, M.D.

Allopathic & Osteopathic Physicians|Family Medicine · HARLAN, KY · NPI 1275528937

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Gregory Brian Dye, M.D. received $35.94 in general payments during 2025 across 2 reported records.

Novo Nordisk Inc accounted for 51.3% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Vraylar.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 158 claims for Linzess by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 64 claims for Synthroid by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported VRAYLAR as an associated drug or biological on 377741 records involving 62704 distinct recipient NPIs. Public Medicare Part D data also shows 20 claims for Vraylar by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 151 claims for Ozempic by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Rybelsus by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$35.94

2 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$18.44	51.3%	1	2025
ABBVIE INC.	Unresolved — no canonical attribution shown	$17.50	48.7%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$35.94	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Wegovy Normalized: wegovy	Drug	Novo Nordisk Inc	$18.44	1	2025
Source payment records 2025-08-25 · Novo Nordisk Inc · $18.44 · Open Payments source
VRAYLAR Normalized: vraylar	Drug	ABBVIE INC.	$17.50	1	2025
Source payment records 2025-09-18 · ABBVIE INC. · $17.50 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
VRAYLAR vraylar	2025	Vraylar	2024	20 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	LINZESS open payments reported associated product	CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608	Linzess · 2024 Exact normalized brand match · 1 Part D row	158	26
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	SYNTHROID open payments reported associated product	CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636	Synthroid · 2024 Exact normalized brand match · 1 Part D row	64	15
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	VRAYLAR open payments reported associated product	CMS Open Payments — General Payments 377741 supporting records · 62704 recipient NPIs · example record 1201352550	Vraylar · 2024 Exact normalized brand match · 1 Part D row	20	suppressed by CMS
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Ozempic open payments reported associated product	CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076	Ozempic · 2024 Exact normalized brand match · 1 Part D row	151	29
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Rybelsus open payments reported associated product	CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076	Rybelsus · 2024 Exact normalized brand match · 1 Part D row	11	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1143	208
Omeprazole	Omeprazole	811	147
Amlodipine Besylate	Amlodipine Besylate	793	162
Lisinopril	Lisinopril	788	151
Furosemide	Furosemide	783	169
Levothyroxine Sodium	Levothyroxine Sodium	752	150
Pantoprazole Sodium	Pantoprazole Sodium	674	136
Metformin Hcl	Metformin Hcl	667	133
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	600	80
Metoprolol Tartrate	Metoprolol Tartrate	595	128
Potassium Chloride	Potassium Chloride	527	107
Metoprolol Succinate	Metoprolol Succinate	524	108
Losartan Potassium	Losartan Potassium	473	98
Gabapentin	Gabapentin	459	73
Hydrochlorothiazide	Hydrochlorothiazide	428	97
Glimepiride	Glimepiride	425	86
Prednisone	Prednisone	420	188
Tamsulosin Hcl	Tamsulosin Hcl	411	81
Trazodone Hcl	Trazodone Hcl	392	77
Clopidogrel	Clopidogrel Bisulfate	373	65
Sertraline Hcl	Sertraline Hcl	357	74
Albuterol Sulfate Hfa	Albuterol Sulfate	347	111
Famotidine	Famotidine	330	53
Meloxicam	Meloxicam	309	71
Eliquis	Apixaban	308	63
Allopurinol	Allopurinol	291	60
Buspirone Hcl	Buspirone Hcl	286	57
Ibuprofen	Ibuprofen	270	70
Jardiance	Empagliflozin	259	42
Fluticasone Propionate	Fluticasone Propionate	247	62
Simvastatin	Simvastatin	245	45
Donepezil Hcl	Donepezil Hcl	240	42
Carvedilol	Carvedilol	237	45
Citalopram Hbr	Citalopram Hydrobromide	236	43
Isosorbide Mononitrate Er	Isosorbide Mononitrate	225	45
Levofloxacin	Levofloxacin	224	131
Diclofenac Sodium	Diclofenac Sodium	218	64
Vitamin D2	Ergocalciferol (Vitamin D2)	216	63
Pravastatin Sodium	Pravastatin Sodium	215	41
Rosuvastatin Calcium	Rosuvastatin Calcium	211	47
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	207	127
Duloxetine Hcl	Duloxetine Hcl	205	41
Montelukast Sodium	Montelukast Sodium	196	42
Tizanidine Hcl	Tizanidine Hcl	189	57
Nitroglycerin	Nitroglycerin	188	66
Escitalopram Oxalate	Escitalopram Oxalate	182	35
Metformin Hcl Er	Metformin Hcl	177	40
Atenolol	Atenolol	174	36
Ondansetron Hcl	Ondansetron Hcl	174	77
Mirtazapine	Mirtazapine	170	27
Tramadol Hcl	Tramadol Hcl	170	29
Alprazolam	Alprazolam	169	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	168	30
Esomeprazole Magnesium	Esomeprazole Magnesium	166	31
Clonidine Hcl	Clonidine Hcl	164	43
Naproxen	Naproxen	161	36
Linzess	Linaclotide	158	26
Amoxicillin	Amoxicillin	157	91
Triamcinolone Acetonide	Triamcinolone Acetonide	154	60
Ozempic	Semaglutide	151	29
Cefdinir	Cefdinir	147	99
Levetiracetam	Levetiracetam	143	23
Ropinirole Hcl	Ropinirole Hcl	137	27
Sucralfate	Sucralfate	133	22
Azithromycin	Azithromycin	132	85
Hydralazine Hcl	Hydralazine Hcl	131	29
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	130	38
Ventolin Hfa	Albuterol Sulfate	126	39
Oxycodone Hcl	Oxycodone Hcl	125	16
Xarelto	Rivaroxaban	123	30
Glipizide	Glipizide	120	21
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	119	67
Topiramate	Topiramate	118	28
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	117	19
Valsartan	Valsartan	116	24
Mounjaro	Tirzepatide	114	24
Paroxetine Hcl	Paroxetine Hcl	113	19
Quetiapine Fumarate	Quetiapine Fumarate	113	22
Fluconazole	Fluconazole	112	52
Meclizine Hcl	Meclizine Hcl	112	40
Lorazepam	Lorazepam	108	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	106	22
Januvia	Sitagliptin Phosphate	102	18
Terazosin Hcl	Terazosin Hcl	101	17
Nifedipine Er	Nifedipine	100	17
Bumetanide	Bumetanide	97	19
Spironolactone	Spironolactone	97	22
Fluoxetine Hcl	Fluoxetine Hcl	94	17
Acetaminophen-Codeine	Acetaminophen With Codeine	93	11
Hydroxyzine Hcl	Hydroxyzine Hcl	91	33
Farxiga	Dapagliflozin Propanediol	89	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	88	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	86	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	84	17
Bupropion Xl	Bupropion Hcl	83	24
Propranolol Hcl	Propranolol Hcl	82	13
Finasteride	Finasteride	81	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	80	40
Pregabalin	Pregabalin	80	12
Entresto	Sacubitril/Valsartan	78	17
Methocarbamol	Methocarbamol	78	21
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	75	20
Diazepam	Diazepam	74	15
Memantine Hcl	Memantine Hcl	74	15
Celecoxib	Celecoxib	73	18
Lansoprazole	Lansoprazole	73	17
Clonazepam	Clonazepam	72	suppressed
Enulose	Lactulose	72	15
Lantus	Insulin Glargine,hum.Rec.Anlog	71	suppressed
Warfarin Sodium	Warfarin Sodium	70	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	68	13
Ezetimibe	Ezetimibe	67	15
Alendronate Sodium	Alendronate Sodium	65	11
Colchicine	Colchicine	65	25
Diltiazem Hcl	Diltiazem Hcl	65	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	65	17
Mupirocin	Mupirocin	64	28
Synthroid	Levothyroxine Sodium	64	15
Metoclopramide Hcl	Metoclopramide Hcl	63	11
Amitriptyline Hcl	Amitriptyline Hcl	61	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	61	14
Cilostazol	Cilostazol	61	11
Nuedexta	Dextromethorphan Hbr/Quinidine	61	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	60	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	59	15
Divalproex Sodium	Divalproex Sodium	58	suppressed
Trulicity	Dulaglutide	58	suppressed
Ranolazine Er	Ranolazine	56	11
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	56	16
Baclofen	Baclofen	55	12
Loperamide	Loperamide Hcl	55	15
Doxycycline Hyclate	Doxycycline Hyclate	54	37
Pioglitazone Hcl	Pioglitazone Hcl	54	13
Glipizide Er	Glipizide	53	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	53	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	52	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	52	11
Latanoprost	Latanoprost	52	suppressed
Novolin R	Insulin Regular, Human	52	13
Enalapril Maleate	Enalapril Maleate	51	13
Invokana	Canagliflozin	50	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	50	12
Symbicort	Budesonide/Formoterol Fumarate	49	16
Doxazosin Mesylate	Doxazosin Mesylate	48	11
Fosinopril Sodium	Fosinopril Sodium	48	suppressed
Chlorthalidone	Chlorthalidone	47	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	47	suppressed
Clindamycin Hcl	Clindamycin Hcl	46	31
Dexamethasone	Dexamethasone	46	39
Levemir Flexpen	Insulin Detemir	46	14
Metolazone	Metolazone	46	11
Temazepam	Temazepam	45	suppressed
Humulin R	Insulin Regular, Human	43	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	42	28
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	42	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	42	16
Carbidopa-Levodopa	Carbidopa/Levodopa	39	suppressed
Methylprednisolone	Methylprednisolone	39	30
Promethazine Hcl	Promethazine Hcl	39	19
Lovastatin	Lovastatin	38	suppressed
Ondansetron Odt	Ondansetron	38	11
Amiodarone Hcl	Amiodarone Hcl	37	12
Ibu	Ibuprofen	37	18
Spiriva Handihaler	Tiotropium Bromide	37	suppressed
Lactulose	Lactulose	36	17
Midodrine Hcl	Midodrine Hcl	36	suppressed
Valacyclovir	Valacyclovir Hcl	36	15
Combivent Respimat	Ipratropium/Albuterol Sulfate	34	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	34	14
Clotrimazole	Clotrimazole	33	20
Ketoconazole	Ketoconazole	33	12
Ramipril	Ramipril	33	suppressed
Bupropion Hcl Sr	Bupropion Hcl	31	suppressed
Morphine Sulfate Er	Morphine Sulfate	31	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	30	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Acarbose	Acarbose	28	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	28	suppressed
Clobetasol Propionate	Clobetasol Propionate	27	16
Hydrocortisone	Hydrocortisone	27	12
Isosorbide Dinitrate	Isosorbide Dinitrate	27	suppressed
Olanzapine	Olanzapine	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	27	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	26	suppressed
Constulose	Lactulose	26	14
Humalog Kwikpen U-100	Insulin Lispro	26	12
Megestrol Acetate	Megestrol Acetate	26	15
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	26	suppressed
Penicillin V Potassium	Penicillin V Potassium	26	12
Pentoxifylline	Pentoxifylline	25	suppressed
Phenobarbital	Phenobarbital	25	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	24	suppressed
Dantrolene Sodium	Dantrolene Sodium	24	suppressed
Divalproex Sodium Er	Divalproex Sodium	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	24	suppressed
Glyburide	Glyburide	23	suppressed
Humalog	Insulin Lispro	23	suppressed
Nystatin	Nystatin	23	17
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	23	suppressed
Tresiba Flextouch U-200	Insulin Degludec	23	suppressed
Estradiol	Estradiol	22	suppressed
Felodipine Er	Felodipine	22	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	22	suppressed
Phenytoin	Phenytoin	22	suppressed
Metronidazole	Metronidazole	21	17
Xifaxan	Rifaximin	21	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	20	suppressed
Clozapine	Clozapine	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Vraylar	Cariprazine Hcl	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	19	11
Cephalexin	Cephalexin	19	13
Klor-Con M20	Potassium Chloride	19	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	19	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Carbamazepine	Carbamazepine	18	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	18	suppressed
Nebivolol Hcl	Nebivolol Hcl	18	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	18	suppressed
Testosterone Cypionate	Testosterone Cypionate	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Cholestyramine Light	Cholestyramine	17	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	17	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	16	suppressed
Doxepin Hcl	Doxepin Hcl	16	suppressed
Tiadylt Er	Diltiazem Hcl	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Ursodiol	Ursodiol	16	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	15	11
Acyclovir	Acyclovir	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Brilinta	Ticagrelor	14	suppressed
Gemtesa	Vibegron	14	suppressed
Memantine Hcl Er	Memantine Hcl	14	suppressed
Roflumilast	Roflumilast	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Tamoxifen Citrate	Tamoxifen Citrate	14	suppressed
Verapamil Hcl	Verapamil Hcl	14	suppressed
Acebutolol Hcl	Acebutolol Hcl	13	suppressed
Calcitriol	Calcitriol	13	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	13	suppressed
Digoxin	Digoxin	13	suppressed
Dilt-Xr	Diltiazem Hcl	13	suppressed
Epinephrine	Epinephrine	13	suppressed
Estradiol (Twice Weekly)	Estradiol	13	suppressed
Flecainide Acetate	Flecainide Acetate	13	suppressed
Indapamide	Indapamide	13	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Albuterol Sulfate	Albuterol Sulfate	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	12	suppressed
Dofetilide	Dofetilide	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	12	suppressed
Indomethacin	Indomethacin	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	12	suppressed
Methimazole	Methimazole	12	suppressed
Nuplazid	Pimavanserin Tartrate	12	suppressed
Procto-Med Hc	Hydrocortisone	12	suppressed
Rytary	Carbidopa/Levodopa	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Aimovig Autoinjector	Erenumab-Aooe	11	suppressed
Balsalazide Disodium	Balsalazide Disodium	11	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	11	suppressed
Bethanechol Chloride	Bethanechol Chloride	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Ertapenem	Ertapenem Sodium	11	suppressed
Glucagon Emergency Kit	Glucagon	11	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	11	suppressed
Pristiq	Desvenlafaxine Succinate	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$35.94 · 2 records	Novo Nordisk Inc	VRAYLAR, Wegovy	5	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Vraylar play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error